Study uses urine tests to understand prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study collects a small urine sample around the time of a prostate biopsy to look for chemical “signals” that may explain dangerous prostate cancer behavior. Your results are not shared with you, but the information may help researchers improve understanding and future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a prostate biopsy, or you had one within the last 6 weeks
- You are a man age 30 to 100
- If you are coming back for another biopsy, your testosterone must be within the normal range (above 1.5 ng/mL)
- You can understand the study and agree to donate one urine sample (about 50 mL) and allow researchers to use your medical and biopsy information
- No other active cancer; if you had another cancer treated with cure, you must be disease-free for 3 years or longer
- In the last 3 months, you have not had certain prostate cancer medicines (chemo, ADT, immunotherapy, targeted therapy), and no pelvic radiation in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
This trial is testing if a simple urine test can help track prostate or bladder cancer over time without needing invasive procedures. It includes five specific patient groups with different stages of these cancers.
This trial collects tumor samples from men with prostate cancer to study the bacteria and other microbes inside the tumor. It aims to learn how these microbes might affect the cancer and treatment.
This study collects and measures “biomarkers” (measurable signs in the body) from people with prostate cancer who are about to have surgery or radiation. The goal is to understand how prostate cancer behaves during treatment, which may help improve care in the future.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
Hear when a new Significant Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.